1. Home
  2. WVE vs AVAH Comparison

WVE vs AVAH Comparison

Compare WVE & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.04

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc.

HOLD

Current Price

$9.50

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
AVAH
Founded
2012
1984
Country
Singapore
United States
Employees
317
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
WVE
AVAH
Price
$6.04
$9.50
Analyst Decision
Strong Buy
Buy
Analyst Count
16
9
Target Price
$29.81
$9.75
AVG Volume (30 Days)
2.2M
1.9M
Earning Date
04-28-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1850.00
EPS
N/A
0.19
Revenue
$3,704,000.00
$2,433,199,000.00
Revenue This Year
N/A
$7.31
Revenue Next Year
$85.67
$5.59
P/E Ratio
N/A
$49.00
Revenue Growth
149.43
20.19
52 Week Low
$5.02
$5.93
52 Week High
$21.73
$10.32

Technical Indicators

Market Signals
Indicator
WVE
AVAH
Relative Strength Index (RSI) 53.05 51.25
Support Level $5.49 $8.89
Resistance Level $6.21 $9.89
Average True Range (ATR) 0.25 0.32
MACD 0.03 -0.11
Stochastic Oscillator 83.54 31.00

Price Performance

Historical Comparison
WVE
AVAH

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.

Share on Social Networks: